The food industry's next growth line is protein, not calories

For fifty years the packaged food industry competed on taste, convenience and price, and its health messaging was mostly about taking things out: less fat, less sugar, fewer calories. Three forces are now pushing in a different direction at the same time. Governments are rewriting dietary advice around protein and whole foods, obesity has reached a scale health systems can no longer ignore, and millions of people on weight-loss medicines are eating less but needing more from what they do eat.

Policy has turned toward protein

The US Dietary Guidelines for 2025–2030, released by the departments of Health and Human Services and Agriculture in January 2026, are the clearest example. They raise the suggested protein intake to 1.2–1.6 grams per kilogram of body weight, against the long-standing reference of 0.8 grams. They tell people to avoid highly processed packaged foods that are salty or sweet, say that no amount of added sugar is part of a healthy diet, and now favour full-fat dairy over low-fat.

Daily protein guidance for adults

Grams per kilogram of body weight

Labelling rules are moving the same way. The US Food and Drug Administration's updated definition of "healthy" on food packs, finalised in December 2024, ties the claim to meaningful amounts of food groups such as fruit, vegetables, dairy and protein foods, with limits on added sugar, sodium and saturated fat. Manufacturers have until February 2028 to comply. In India, the ICMR–National Institute of Nutrition's 2024 dietary guidelines estimate that 56.4% of the country's total disease burden is linked to unhealthy diets.

The demand behind it

The World Health Organization's numbers explain the urgency. In 2022, 43% of adults worldwide were overweight, up from 25% in 1990, and obesity among children and adolescents rose from 2% to 8% over the same period. WHO projects the economic cost of obesity could reach US$3 trillion a year by 2030 and more than US$18 trillion by 2060.

Overweight and obesity, worldwide

Per cent of each population group

The geography matters. WHO's figures range from about 31% of adults overweight in South-East Asia and Africa to 67% in the Americas. That points to two different markets: treatment-adjacent nutrition where obesity is already widespread, and prevention and affordable protein where it is rising from a lower base.

Weight-loss medicines change the basket

People taking GLP-1 medicines eat smaller portions, and clinicians advise them to protect muscle with enough protein, fibre and micronutrients. The user base is large and growing: Novo Nordisk alone reached 4.9 million people with its obesity medicines in the first half of 2026, and generic semaglutide in India is now selling at half the original price or less.

Food companies have noticed. Nestlé Health Science launched a dedicated nutrition platform for GLP-1 users in 2024, drawing on brands such as Boost, Garden of Life, Nature's Bounty, Nuun and Vital Proteins, and followed it with Vital Pursuit, a range of high-protein frozen meals in the US. Danone has built its recent growth around high-protein products: retail sales of its Oikos brand rose about 40% in 2024 and high-protein lines kept growing at double digits in 2025. A Danone executive put the share of US consumers wanting more protein at three in four.

Where the opportunity sits

The United States combines a policy push, high obesity rates and the largest population on weight-loss drugs. Products that are high in protein and fibre per calorie, in smaller portions, are the most direct fit.

India and South Asia are a prevention market. Rising diet-related disease, a large vegetarian population and price sensitivity favour dairy, pulses and fortified staples over premium supplements, and cheaper semaglutide will add a treatment segment within a few years.

Ingredients sit underneath both. Whey and milk proteins, plant proteins, fibres and fortificants are the inputs every reformulated product needs.

What this means for leaders

• Reformulate on nutrient density. The winning measure is protein and fibre per calorie, not just less sugar or fat. Portfolios built on indulgence need a clear plan for the share of sales that will shift.
• Claims need evidence. With the FDA's "healthy" rule and tighter labelling in India, every front-of-pack claim needs to stand up to regulators and to consumers who read labels.
• Pack sizes and price points will change. Smaller appetites mean smaller portions, and per-unit margins need to be designed for that rather than discovered.
• New channels open. Clinics, pharmacies and telehealth providers prescribing weight-loss drugs are becoming routes to market for nutrition products.

The consumer of the next decade is eating less and asking more of every mouthful. That is a product problem before it is a marketing one.

Figures are as published by the sources above at the time of writing. Forecasts and company guidance are labelled as such and will change.

← Back to all insights